Login / Signup

Deep mutational scanning of essential bacterial proteins can guide antibiotic development.

Liselot DewachterAaron N BrooksKatherine NoonCharlotte CialekAlia Clark-ElSayedThomas SchalckNandini KrishnamurthyWim VerséesWim F VrankenJan Michiels
Published in: Nature communications (2023)
Deep mutational scanning is a powerful approach to investigate a wide variety of research questions including protein function and stability. Here, we perform deep mutational scanning on three essential E. coli proteins (FabZ, LpxC and MurA) involved in cell envelope synthesis using high-throughput CRISPR genome editing, and study the effect of the mutations in their original genomic context. We use more than 17,000 variants of the proteins to interrogate protein function and the importance of individual amino acids in supporting viability. Additionally, we exploit these libraries to study resistance development against antimicrobial compounds that target the selected proteins. Among the three proteins studied, MurA seems to be the superior antimicrobial target due to its low mutational flexibility, which decreases the chance of acquiring resistance-conferring mutations that simultaneously preserve MurA function. Additionally, we rank anti-LpxC lead compounds for further development, guided by the number of resistance-conferring mutations against each compound. Our results show that deep mutational scanning studies can be used to guide drug development, which we hope will contribute towards the development of novel antimicrobial therapies.
Keyphrases
  • genome editing
  • crispr cas
  • high resolution
  • high throughput
  • electron microscopy
  • copy number
  • single cell
  • stem cells
  • gene expression
  • mesenchymal stem cells
  • cell therapy